
    
      To determine:

        -  Duration of response

        -  Progression free survival

        -  Proportion of responders 2 years after discontinuation of inecalcitol

        -  Duration of response after discontinuation of inecalcitol and imatinib

        -  Bone remodelling effect

        -  Safety of inecalcitol in combination with imatinib

        -  Quality of Life
    
  